Style | Citing Format |
---|---|
MLA | Abbasian R, et al.. "Mizaj Assessment in Multiple Sclerosis (Ms) Patients Based on Persian Medicine." Journal of Complementary and Integrative Medicine, vol. 19, no. 2, 2022, pp. 401-408. |
APA | Abbasian R, Mojahedi M, Alizadeh M, Khafri S, Ansaripour M, Moosavyzadeh A, Kamali M, Babaeian M, Sourtiji H, Shaygannejad V, Kerdarian H, Rezaeizadeh H (2022). Mizaj Assessment in Multiple Sclerosis (Ms) Patients Based on Persian Medicine. Journal of Complementary and Integrative Medicine, 19(2), 401-408. |
Chicago | Abbasian R, Mojahedi M, Alizadeh M, Khafri S, Ansaripour M, Moosavyzadeh A, Kamali M, et al.. "Mizaj Assessment in Multiple Sclerosis (Ms) Patients Based on Persian Medicine." Journal of Complementary and Integrative Medicine 19, no. 2 (2022): 401-408. |
Harvard | Abbasian R et al. (2022) 'Mizaj Assessment in Multiple Sclerosis (Ms) Patients Based on Persian Medicine', Journal of Complementary and Integrative Medicine, 19(2), pp. 401-408. |
Vancouver | Abbasian R, Mojahedi M, Alizadeh M, Khafri S, Ansaripour M, Moosavyzadeh A, et al.. Mizaj Assessment in Multiple Sclerosis (Ms) Patients Based on Persian Medicine. Journal of Complementary and Integrative Medicine. 2022;19(2):401-408. |
BibTex | @article{ author = {Abbasian R and Mojahedi M and Alizadeh M and Khafri S and Ansaripour M and Moosavyzadeh A and Kamali M and Babaeian M and Sourtiji H and Shaygannejad V and Kerdarian H and Rezaeizadeh H}, title = {Mizaj Assessment in Multiple Sclerosis (Ms) Patients Based on Persian Medicine}, journal = {Journal of Complementary and Integrative Medicine}, volume = {19}, number = {2}, pages = {401-408}, year = {2022} } |
RIS | TY - JOUR AU - Abbasian R AU - Mojahedi M AU - Alizadeh M AU - Khafri S AU - Ansaripour M AU - Moosavyzadeh A AU - Kamali M AU - Babaeian M AU - Sourtiji H AU - Shaygannejad V AU - Kerdarian H AU - Rezaeizadeh H TI - Mizaj Assessment in Multiple Sclerosis (Ms) Patients Based on Persian Medicine JO - Journal of Complementary and Integrative Medicine VL - 19 IS - 2 SP - 401 EP - 408 PY - 2022 ER - |